XPO Logistics Named a 2020 Great Supply Chain Partner by SupplyChainBrain
GREENWICH, Conn., Aug. 11, 2020 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and […]
Golden Minerals Drills 23.4m Grading 5.96 g/t Au at Rodeo Gold Project, Durango, Mexico
GOLDEN, Colo., Aug. 11, 2020 (GLOBE NEWSWIRE) — Golden Minerals Company (“Golden Minerals”, “Golden” or the “Company”) (NYSE American and […]
Affimed Reports Second Quarter 2020 Financial Results and Operational Progress
Continued progress in the AFM13 pTCL REDIRECT monotherapy studyAFM24 is recruiting patients in cohort 2 of a Phase 1/2a clinical […]
Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]
CentoMD® Update Reveals Further Insights Into Rare Diseases
CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused […]
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]
Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
Preliminary Data Demonstrates Normalization of CSF GBA1 Enzyme Activity in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease PatientsCompany […]
Bilibili to Report Second Quarter 2020 Financial Results on Wednesday, August 26, 2020
SHANGHAI, China, Aug. 11, 2020 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI), a leading online entertainment […]
WeedMD Enters into Commercial Arrangement with Fire & Flower to produce CBD Cannabis Products
TORONTO, Aug. 11, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
~ No Clinical Safety or Efficacy Issues Identified, and No Requirement for Further Clinical Data ~~ FDA Pre-Approval Inspection has […]
